These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30055465)

  • 61. Design, synthesis and biological evaluation of Lenalidomide derivatives as tumor angiogenesis inhibitor.
    Hu S; Yuan L; Yan H; Li Z
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4075-4081. PubMed ID: 28757066
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
    Elsayed NMY; Serya RAT; Tolba MF; Ahmed M; Barakat K; Abou El Ella DA; Abouzid KAM
    Bioorg Chem; 2019 Feb; 82():340-359. PubMed ID: 30428414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-lung Cancer and Anti-angiogenic Activities of New Designed Boronated Phenylalanine Metal Complexes.
    Varol M; Koparal AT; Benkli K; Bostancioglu RB
    Curr Drug Deliv; 2018; 15(10):1417-1425. PubMed ID: 30051790
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
    Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
    Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
    Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
    J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4.
    Li C; Shan Y; Sun Y; Si R; Liang L; Pan X; Wang B; Zhang J
    Eur J Med Chem; 2017 Dec; 141():506-518. PubMed ID: 29102175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and biological activity of Schiff base series of valproyl, N-valproyl glycinyl, and N-valproyl-4-aminobenzoyl hydrazide derivatives.
    El-Faham A; Farooq M; Khattab SN; Elkayal AM; Ibrahim MF; Abutaha N; Wadaan MA; Hamed EA
    Chem Pharm Bull (Tokyo); 2014; 62(6):591-9. PubMed ID: 24881666
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.
    Qian X; Zhu L; Hu J; Li M; Xie L; Wang L; Yu L; Liu B
    J Ethnopharmacol; 2012 Aug; 143(1):256-61. PubMed ID: 22750432
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
    Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
    J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
    Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
    Narise K; Okuda K; Enomoto Y; Hirayama T; Nagasawa H
    Drug Des Devel Ther; 2014; 8():701-17. PubMed ID: 24944508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings.
    Rodić MV; Leovac VM; Jovanović LS; Spasojević V; Joksović MD; Stanojković T; Matić IZ; Vojinović-Ješić LS; Marković V
    Eur J Med Chem; 2016 Jun; 115():75-81. PubMed ID: 27084495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells.
    Basappa ; Ananda Kumar CS; Nanjunda Swamy S; Sugahara K; Rangappa KS
    Bioorg Med Chem; 2009 Jul; 17(14):4928-34. PubMed ID: 19556138
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
    Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
    Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition.
    Gao L; Wang L; Sun Z; Li H; Wang Q; Yi C; Wang X
    Drug Des Devel Ther; 2017; 11():1789-1802. PubMed ID: 28670112
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.
    Kaji K; Nishimura N; Seki K; Sato S; Saikawa S; Nakanishi K; Furukawa M; Kawaratani H; Kitade M; Moriya K; Namisaki T; Yoshiji H
    Int J Cancer; 2018 Apr; 142(8):1712-1722. PubMed ID: 29205334
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of novel isatin-dehydroepiandrosterone conjugates as potential anticancer agents.
    Ke S; Shi L; Yang Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4628-31. PubMed ID: 26320625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 5-Acetamido-1-(methoxybenzyl) isatin inhibits tumor cell proliferation, migration, and angiogenesis.
    Zhang Q; Fu Y; Zhao Y; Cui S; Wang J; Liu F; Yuan Y; Galons H; Yu P; Teng Y
    RSC Adv; 2019 Nov; 9(63):36690-36698. PubMed ID: 35539063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.